<DOC>
	<DOCNO>NCT02645370</DOCNO>
	<brief_summary>The purpose evaluate effectiveness safety profile Danzhen prophylaxis migraine `` real-world '' setting .</brief_summary>
	<brief_title>Efficacy Safety Danzhen</brief_title>
	<detailed_description>In adult 18- 65-years China , prevalence migraine 9.3 % general . Migraine heterogeneous condition may produce range symptom profile various degree disability.The disability result migraine severe impose considerable health burden upon sufferer society . The purpose study , use topiramate control , evaluate effectiveness safety Danzhen prophylaxis migraine `` real-world '' setting.Patients ask maintain detailed headache diary via headache diary APP throughout treatment period .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Patients older equal 18 year less 70 year . The diagnosis migraine make accord 2004 The International Classification Headache Disorders : 2nd edition ( ICHDII ) . Consent form sign participant his/her authorize surrogate . Patients primary secondary headache disorder migraine . Female subject childbearing age exclude pregnant , lactate plan apregnancy next year use adequate form birth control . Patients exclude significant medical psychiatric disease , take another antidepressant reason able discontinue . Patients use preventive pharmacological agent 1 month prior baseline period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Danzhen</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Headache diary APP</keyword>
	<keyword>preventive treatment</keyword>
</DOC>